LANSING, Mich. (Michigan News Source) – Flu season is back, bringing its annual collection of coughing, sneezing, feverish misery – and this year, another question for Michiganders: Are all those flu shots being offered at pharmacies now made with mRNA technology?
The short answer is no, not all of them. And yes, you can still request a traditional flu vaccine.
Michigan Flu Numbers Are Climbing
MORE NEWS: MSU Says Student, Employee Information May Have Been Exposed in Cybersecurity Threat
According to the Michigan Department of Health and Human Services (MDHHS) and their week ending October 31 “Michigan Flu Focus” report, influenza accounted for approximately 0.6% of emergency department visits in late October, up from roughly 0.14% in late September. And as of October 31, only 13.8% of Michigan residents had received a flu vaccine this season.
Nationally, the CDC estimates at least 1.7 million illnesses, 25,000 hospitalizations and 1,400 deaths so far this flu season.
New mRNA Shot Joins the Lineup – But is it Safe?
The FDA approved Moderna’s new mRNA flu vaccine, mFLUSIVA, in August for adults 50 and older.
However, according to experts, safety concerns are reportedly being raised following reports of adverse reactions. According to Children’s Health Defense, an analysis of the federal Vaccine Adverse Event Reporting System (VAERS) identified 78 reports involving the vaccine during September and October 2026, including two officially classified as serious, where patients lost the ability to walk. More than half of the events reported were linked to people 65-79 years old.
The article also states that 37 of the 78 reports involved people who received both the flu and COVID-19 vaccines around the same time, including 30 who received them on the same day.
Reported incidents included temporary inability to walk, hospitalization involving fever and low oxygen levels, and hallucinations. Some experts cited in the article are calling for the vaccine’s suspension. Brian, Ph.D., chief scientific officer for the Children’s Health Defense says, “The flurry of reports that has accumulated in VAERS in just two months is stunning, especially given that this was a limited launch of the vaccine and the majority of pharmacies didn’t have stock until late September or early October. Also, the proportion of serious adverse events is high.” He adds that mFLUSIVA data show that “the risk far exceeds the benefit,” especially for the elderly.
FDA Review Raises Concerns Over Side Effects and Vaccine Safety
MORE NEWS: Gobble Up the Savings: Thanksgiving Dinner Costs Fall as Turkey Prices Drop
Several experts also raised concerns that mFLUSIVA’s clinical trials did not assess the safety of administering the vaccine alongside a COVID-19 shot, even though public health officials encourage people to receive both vaccines during the fall respiratory illness season.
According to a peer-reviewed reanalysis of mFLUSIVA clinical trial data, the vaccine produced more side effects than traditional flu vaccines during clinical trials. Approximately 75.7% of recipients reported reactions, compared with 46.7% receiving conventional vaccines. Common complaints included fatigue, headaches, muscle and joint pain, chills and injection-site pain. Severe systemic reactions were also more frequent, occurring in 5.5% of mFLUSIVA recipients compared with 0.9% in the comparison group. The FDA also identified certain serious conditions requiring continued safety monitoring, although it did not establish that the vaccine caused them.
Patients Have a Choice
For those concerned about the reported side effects or simply uncomfortable with mRNA technology, the good news is that getting a flu shot doesn’t have to mean getting an mRNA vaccine. Traditional options remain available. Non-mRNA vaccines include Fluzone, Fluarix, Flulaval, Flucelvax and Flublok. These use egg-based, cell-based or recombinant technology instead. That means they are manufactured using traditional methods or established protein-based technology rather than mRNA instructions that tell the body’s cells to produce a viral protein. All three approaches are designed to trigger an immune response against influenza without using mRNA technology.
Yes, You Can Ask for a Traditional Shot
Michiganders who prefer avoiding mRNA technology can ask their pharmacist or healthcare provider which vaccine they’re offering and request a non-mRNA alternative. Availability varies by location, so calling ahead is smart.
The bottom line? Flu season may not give Michiganders much choice about which viruses come knocking, but they still have a choice about which type of flu vaccine goes into their arm.
